USADA announced today that a three-member panel of the American Arbitration Association (AAA) has rendered an operative award in the case of bobsled athlete, Ryan Bailey, of Sherwood, Ore., and has determined that Bailey should receive a six-month sanction after testing positive for a prohibited substance. The AAA panel will issue a reasoned award within 30 days.

Bailey, 28, tested positive for 1,3-dimethylbutylamine (DMBA) as the result of an in-competition urine sample he provided on January 10, 2017, at the International Bobsleigh and Skeleton Federation (IBSF) North American Cup. DMBA is a Specified Substance in the class of Stimulants and prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the IBSF Anti-Doping Rules, all of which have adopted the World Anti-Doping Code (the Code) and the World Anti-Doping Agency (WADA) Prohibited List.

The AAA Panel accepted Bailey’s explanation that his positive test was caused by his use of a high risk dietary supplement. Detailed analysis conducted on the supplement by the WADA-accredited laboratory in Salt Lake City, Utah, confirmed that the supplement contained DMBA. Although DMBA was not listed on the Supplement Facts label, another closely related prohibited stimulant, methylhexaneamine, also known as 1,3-Dimethylamylamine (DMAA), was listed on the label.

• This media release was originally published by the US Anti-Doping Agency (USADA) on 3 August 2017. To access the original, please click here.